Discretionary transaction by Janus Henderson Group Plc of tradable shares of ARCA Biopharma subject to Rule 16b-3
About 67% of ABIO Old's investor base is looking to short. The analysis of current outlook of investing in ABIO Old suggests that many traders are alarmed regarding ABIO Old's prospects. ABIO Old's investing sentiment overview a quick insight into current market opportunities from investing in ABIO Old. Many technical investors use ABIO Old stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
ABIO |
Filed transaction by ARCA Biopharma 10 Percent Owner. Discretionary transaction in accordance with Rule 16b-3(f)
Read at macroaxis.com
ABIO Old Fundamental Analysis
We analyze ABIO Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIO Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIO Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
ABIO Old is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
ABIO Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ABIO Old stock to make a market-neutral strategy. Peer analysis of ABIO Old could also be used in its relative valuation, which is a method of valuing ABIO Old by comparing valuation metrics with similar companies.
Peers
ABIO Old Related Equities
TIL | Instil Bio | 22.36 | ||||
FBRX | Forte Biosciences | 8.78 | ||||
NXTC | NextCure | 7.50 | ||||
ADAG | Adagene | 5.00 | ||||
TPST | Tempest Therapeutics | 4.55 | ||||
RZLT | Rezolute | 3.74 | ||||
CTMX | CytomX Therapeutics | 3.57 | ||||
KTTA | Pasithea Therapeutics | 2.89 | ||||
AVTE | Aerovate Therapeutics | 1.19 | ||||
ANTX | AN2 Therapeutics | 0.79 | ||||
ACRV | Acrivon Therapeutics, | 0.88 | ||||
INDP | Indaptus Therapeutics | 2.11 | ||||
SPRO | Spero Therapeutics | 3.33 | ||||
RNXT | RenovoRx | 3.90 | ||||
QNRX | Quoin Pharmaceuticals | 30.51 |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in ABIO Stock
If you are still planning to invest in ABIO Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIO Old's history and understand the potential risks before investing.
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |